PIGLIUCCI RICCARDO

CIK 00011970872 companiesSUNNYVALE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001197087

Recent Transactions

46 trades

Exercise/Conversion
DIONEX CORP /DE
Common Stock
2005-08-16$30.81/sh+1,350→ 5,700 total
Exercise of In-Money
DIONEX CORP /DE
Non-qualified Stock Option
2005-08-16$30.81/sh−4,000→ 16,000 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2005-08-16$30.81/sh+4,000→ 7,000 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2005-08-16$30.81/sh+1,350→ 5,700 total
Sale
DIONEX CORP /DE
Common Stock
2005-08-16$48.20/sh−2,650→ 4,350 total
Exercise of In-Money
DIONEX CORP /DE
Non-qualified Stock Option
2005-08-16$30.81/sh−4,000→ 16,000 total
Sale
DIONEX CORP /DE
Common Stock
2005-08-16$48.20/sh−2,650→ 4,350 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2005-08-16$30.81/sh+4,000→ 7,000 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2004-10-25$45.75/sh+500→ 3,000 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2004-10-25$45.75/sh+3,500→ 6,000 total
Sale
DIONEX CORP /DE
Common Stcok
2004-10-25$54.87/sh−100→ 4,000 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$55.00/sh−100→ 3,700 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$54.79/sh−800→ 4,100 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$55.13/sh−1,100→ 4,900 total
Sale
DIONEX CORP /DE
Comon Stock
2004-10-25$55.01/sh−1,200→ 2,500 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$54.97/sh−200→ 3,800 total
Exercise of In-Money
DIONEX CORP /DE
Directors Stock Option (right to buy)
2004-10-25$45.75/sh−4,000→ 16,000 total
Sale
DIONEX CORP /DE
Common Stcok
2004-10-25$54.87/sh−100→ 4,000 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$54.97/sh−200→ 3,800 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$55.00/sh−100→ 3,700 total
Sale
DIONEX CORP /DE
Comon Stock
2004-10-25$55.01/sh−1,200→ 2,500 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2004-10-25$45.75/sh+500→ 3,000 total
Exercise of In-Money
DIONEX CORP /DE
Directors Stock Option (right to buy)
2004-10-25$45.75/sh−4,000→ 16,000 total
Exercise/Conversion
DIONEX CORP /DE
Common Stock
2004-10-25$45.75/sh+3,500→ 6,000 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$55.13/sh−1,100→ 4,900 total
Sale
DIONEX CORP /DE
Common Stock
2004-10-25$54.79/sh−800→ 4,100 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 20,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 18,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 19,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 20,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 17,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 17,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 19,000 total
Award
DIONEX CORP /DE
Non-Qualified Stock Option
2004-10-22$54.86/sh+1,000→ 18,000 total
Award
INFINITY PHARMACEUTICALS, INC.
Common Stock
2004-07-12+100,000→ 791,507 total
Award
INFINITY PHARMACEUTICALS, INC.
Common Stock
2004-07-12+100,000→ 791,507 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 19,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 20,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 17,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 18,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 20,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 19,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 18,000 total
Award
DIONEX CORP /DE
Directors Stock Option
2003-10-24$41.03/sh+1,000→ 17,000 total
Award
INFINITY PHARMACEUTICALS, INC.
Common Stock
2003-08-04+75,000→ 616,507 total
Award
INFINITY PHARMACEUTICALS, INC.
Common Stock
2003-08-04+75,000→ 616,507 total

Companies

Recent Filings

Address

1228 TITAN WAY

SUNNYVALE, CA, 94085

View on SEC.gov